Transition of Care, Part 1: Going From Your Specialty Center to Your Community Team
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Transition of Care, Part 1: Going From Your Specialty Center to Your Community Team
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Part 1 of this two-part Myeloma Matters episode focuses on introducing the concept of transition of care for myeloma patients: how treatment often begins at specialized centers and then shifts to local providers. Dr. Joshua Dower of Stamford Health explains why CAR T and bispecific therapies typically start at specialty centers, how care teams coordinate, and what early co-management betweenacademic and local doctors looks like. Myeloma patients Kim and Annie discuss their experiences with navigating this transition. This episode also touches on finding myeloma specialists, building trust with care teams, and the rolecaregivers fill in the early treatment phases.
Topics of discussion:
(01:51) Why treatment often starts at academic or specialized cancer centers
(03:40) Choosing bispecific antibody or CAR T-cell therapy
(05:54) Finding a myeloma specialist
(11:48) The path from specialized center to local care
(14:24) Caregiver roles
(18:04) Final thoughts
This episode is supported by Pfizer Inc.
To learn more about bispecific antibody and CAR T-cell therapy, download the Immunotherapy booklet here.
To learn more about multiple myeloma, visit themmrf.org.
To learn more about the MMRF’s FREE resources for patients and caregivers, visit the MMRF Education Hub.
If you have additional questions, call our MMRF Patient Navigation Center at 1-888-841- 6673.